Treating a Patient With HER2-Negative Chemotherapy-Resistant mBC

August 13, 2014
Ragene Rivera, MD

Ragene Rivera, MD, medical oncologist, Texas Oncology-El Paso Cancer Treatment Center, discusses the next treatment steps for a patient with HER2-negative chemotherapy-resistant metastatic breast cancer.

Ragene Rivera, MD, medical oncologist, Texas Oncology-El Paso Cancer Treatment Center, discusses the next treatment steps for a patient with HER2-negative chemotherapy-resistant metastatic breast cancer.

This segment is a part of our Case-Based Peer Perspectives.View the case details > >